Hydrafacial Investor Conference Presentation Deck slide image

Hydrafacial Investor Conference Presentation Deck

Reconciliation of Gross Profit to Adjusted Gross Profit ($mm) Net sales Less: cost of sales Gross profit Gross margin RECONCILIATION OF NON-GAAP MEASURES Adjusted to exclude the following: Stock-based compensation expense Depreciation and amortization expense Adjusted gross profit Adjusted gross margin Year Ended December 31, 2020 $119.1 ($51.9) $67.2 56.4% 2021 $260.1 ($78.3) $181.8 69.9% 0.4 10.3 $192.5 74.0% 10.8 $78.0 65.5% 2019 $166.6 ($60.1) $106.5 63.9% 11.3 $117.8 70.7% Reconciliation of Net Loss to Adjusted EBITDA and Adjusted EBITDA Margin Year Ended December 31, 2020 $119.1 20 ($mm) Net sales Net income (loss) Adjusted to exclude the following: Change in fair value of warrant liability Change in fair value of earn-out shares liability Depreciation amortization expense Stock-based compensation expense Interest expense Income tax benefit Foreign currency loss, net Other expense (income) Management fees¹ Transaction related costs² Other non-recurring and one-time fees³ Adjusted EBITDA Adjusted EBITDA margin 2021 $260.1 (375.1) 277.3 47.1 17.8 12.4 11.8 (2.2) 0.1 4.5 0.2 34.9 4.0 $32.7 12.6% (29.2) 14.5 0.4 21.3 (9.3) 0.0 1.5 4.2 4.3 $7.7 6.5% 2019 $166.6 (1.6) 13.9 0.1 17.1 (1.3) (0.2) (0.5) 1.8 1.7 5.7 $36.7 22.0% ! Represents quarterly management fees paid to the former majority shareholder of the Company based on a pre-determined formula. Following the Business Combination, these fees are no longer paid. 2 For the year ended December 31, 2021, such amounts primarily represent direct costs incurred with the Business Combination, including $21.0 million paid to the former owner of HydraFacial, and to prepare HydraFacial to be marketed for sale by HydraFacial's shareholders in previous periods. 3 For year ended December 31, 2021, such costs primarily represent one-time retention awards related to the distributor acquisitions and executive recruiting and severance fees. For the year ended December 31, 2020, such costs primarily represent COVID-19 related restructuring cost of $3.2 million, including write-off of expired Consumables, discontinued product lines, human capital, cash management consultant fees, and, to a lesser extent, costs associated with a former warehouse and assembly facility during the transition period. For the year ended December 31, 2019, such costs include approximately $4.0 million related to the move from a former warehouse and assembly facility to a new warehouse and assembly facility, approximately $1.4 million to defend certain patents that were being infringed upon, and personnel costs associated with the restructuring of HydraFacial's salesforce, partially offset by a legal settlement received in favor of HydraFacial.
View entire presentation